{"actinic keratosis": 19.38, "alanine aminotransferase increased": 3.14, "arthritis": 2.94, "ascites": 2.26, "aspartate aminotransferase increased": 3.16, "aspergillus infection": 7.21, "basal cell carcinoma": 8.18, "blood alkaline phosphatase increased": 2.78, "blood bilirubin increased": 2.47, "blood creatinine increased": 3.58, "bone marrow failure": 3.48, "bronchopulmonary aspergillosis": 4.59, "c-reactive protein abnormal": 9.94, "c-reactive protein increased": 3.34, "candida infection": 4.96, "cellulitis": 2.33, "cholestasis": 3.39, "chronic graft versus host disease": 16.86, "clear cell renal cell carcinoma": 31.22, "clostridium difficile infection": 3.41, "colitis": 8.83, "colitis ulcerative": 10.9, "condition aggravated": 2.35, "contraindicated product administered": 3.69, "crohn's disease": 9.09, "cushingoid": 16.08, "cytomegalovirus infection": 11.3, "cytomegalovirus infection reactivation": 8.85, "cytomegalovirus test positive": 12.36, "cytomegalovirus viraemia": 12.37, "cytopenia": 2.13, "diffuse large b-cell lymphoma": 3.98, "disease recurrence": 2.75, "drug hypersensitivity": 6.13, "drug ineffective": 3.8, "drug ineffective for unapproved indication": 9.33, "drug intolerance": 9.89, "drug-induced liver injury": 3.62, "eosinophilic granulomatosis with polyangiitis": 13.46, "epstein-barr virus infection": 21.65, "exposure during pregnancy": 3.96, "foetal anaemia": 358.13, "foetal exposure during pregnancy": 7.26, "foetal growth restriction": 19.15, "frequent bowel movements": 5.0, "gamma-glutamyltransferase increased": 2.27, "gastrointestinal disorder": 3.13, "graft versus host disease": 4.7, "haemodialysis": 11.49, "haemophagocytic lymphohistiocytosis": 6.97, "haemorrhage foetal": 483.65, "haemorrhage in pregnancy": 40.57, "heart transplant rejection": 34.8, "hepatic enzyme increased": 3.52, "hepatitis": 3.65, "hepatitis cholestatic": 8.57, "hepatosplenomegaly": 14.02, "hepatotoxicity": 5.23, "herpes simplex": 7.61, "immunosuppression": 7.31, "inflammation": 4.95, "inflammatory bowel disease": 6.56, "infusion site thrombosis": 264.25, "jaundice": 2.45, "joint swelling": 2.63, "kidney transplant rejection": 19.31, "leukopenia": 3.99, "live birth": 31.19, "liver function test abnormal": 8.05, "liver function test increased": 3.98, "low birth weight baby": 6.75, "lung infiltration": 4.52, "lymphocyte count decreased": 3.18, "lymphoma": 2.94, "lymphopenia": 3.67, "maternal exposure during pregnancy": 5.12, "myopathy": 6.31, "myositis": 2.82, "nephropathy toxic": 6.35, "neutrophil count increased": 6.65, "night sweats": 5.31, "nocardiosis": 19.62, "normal newborn": 17.79, "obstruction": 21.58, "off label use": 2.54, "pancreatitis": 3.96, "pancytopenia": 3.96, "pneumocystis jirovecii pneumonia": 4.62, "polyomavirus-associated nephropathy": 15.93, "post transplant lymphoproliferative disorder": 24.61, "pregnancy": 5.25, "premature baby": 10.53, "premature delivery": 10.6, "premature labour": 26.44, "product use in unapproved indication": 3.1, "product use issue": 2.02, "pulmonary mass": 3.28, "quality of life decreased": 4.49, "red blood cell sedimentation rate abnormal": 22.73, "red blood cell sedimentation rate increased": 7.76, "renal transplant failure": 39.85, "scleroderma": 9.36, "sepsis": 2.67, "septic shock": 3.53, "skin infection": 11.03, "skin lesion": 3.82, "skin mass": 5.96, "splenomegaly": 6.27, "squamous cell carcinoma of skin": 17.21, "staphylococcal infection": 2.62, "synovitis": 8.08, "systemic lupus erythematosus": 3.26, "therapeutic product effect decreased": 12.91, "therapeutic product effect incomplete": 5.51, "therapy non-responder": 2.51, "thrombotic microangiopathy": 3.7, "transaminases increased": 3.38, "transplant rejection": 12.97, "treatment failure": 12.8, "tuberculosis": 4.01, "tubulointerstitial nephritis": 3.61, "vasculitis": 4.08, "viral infection": 2.31, "weight decreased": 3.05}